Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
7
×
Tags
biotech
boston blog main
boston top stories
7
×
deals
7
×
ipo
7
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
cancer
new york blog main
new york top stories
san diego blog main
san diego top stories
startups
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
clinical trials
eli lilly
fda
genentech
medicare
novartis
pfizer
What
bio
roundup
new
pharmaceutical
biotech
cancer
drug
drugs
gene
ipo
life
medicines
millions
science
typically
aiming
alzheimer’s
ambys
appetite
bails
becker
big
billions
black
brand
bread
bridgebio
butter
buyout
capital
car
cash
companies
company
control
deadly
deal
debut
debuted
despite
Language
unset
Current search:
ipo
×
photo
×
deals
×
" boston top stories "
×
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?